Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anus Neoplasms × Probiotics × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5 Stomach Neoplasms 3 Malnutrition 2 Carcinoma, Hepatocellular 2 Psychological Well-Being 1 Motor Activity 1 Lung Neoplasms 1 Liver Cirrhosis 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Esophageal Neoplasms 1 Endotoxemia 1 Diarrhea 1 Anus Neoplasms 1 Adenomatous Polyposis Coli 1

Interventions

Fluorouracil 23 Mitomycin 16 Radiotherapy 15 Capecitabine 12 Cisplatin 11 pembrolizumab 9 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 8 Biopsy 8 Radiation 7 fludarabine 6 Specimen Handling 6 Paclitaxel 6 Nivolumab 6 Surveys and Questionnaires 5 Drug Therapy 5 Cetuximab 5 Carboplatin 5 dehydroftorafur 4 Vaccines 4 Papillomavirus Vaccines 4 Observation 4 Irinotecan 4 aldesleukin 3 Watchful Waiting 3 Radiotherapy, Intensity-Modulated 3 Oxaliplatin 3 Light Coagulation 3 Ipilimumab 3 Interleukin-2 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡